###begin article-title 0
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3,</italic>
Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet's disease in a Chinese population with ophthalmic manifestations
###end article-title 0
###begin p 1
Dr. Li and Dr. Zhao contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Studies have shown a strong association of human leukocyte antigens-B51 (HLA-B51) with Behcet's disease (BD). However, little is known about the association of non-HLA genes with BD. The polymorphisms of the Fc receptor-like 3 gene (FCRL3), -169C/T, -110A/G, +358C/G, and +1381A/G, have been reported to be associated with several autoimmune diseases. This study was designed to determine whether the polymorphisms of FCRL3 were associated with susceptibility to BD in a Chinese population mainly with ocular involvement.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
A case-control study was performed in 245 Chinese BD patients and 289 controls. Four single nucleotide polymorphisms (SNPs; -169C/T, -110A/G, +358C/G, and +1381A/G) in FCRL3 were detected using polymerase chain reaction restriction fragment length polymorphisms (PCR-RFLP). HLA-B51 genotyping was performed by the PCR sequence specific primers method as described previously.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 174 175 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 449 454 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 545 552 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
The results showed a significantly higher frequency of the G allele at the -110 site in BD patients compared with that in controls (corrected p=0.044, 75.3% versus 67.5%, chi2=7.72). Haplotype CGCG frequency was significantly higher in patients than in controls (corrected p=0.0096) whereas haplotype TACG frequency was significantly lower in patients compared with controls (corrected p=0.032). There was no relationship between clinical signs and FCRL3 polymorphisms. No significant difference was observed between patients and controls after HLA-B51 stratification concerning the four SNPs.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
Our study suggests that the -110 G allele and the haplotype CGCG of FCRL3 are positively associated with BD in a Chinese population and that the haplotype ATCG might be a protective haplotype for BD.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 770 777 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ICAM-1</italic>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 861 870 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF&#8211;&#945;</italic>
###xml 873 874 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 937 944 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 1023 1024 1015 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1025 1026 1017 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1086 1087 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
Behcet's disease (BD) is an idiopathic, multisystem, recurrent chronic inflammatory disease in China. The major clinical manifestations include recurrent oral and genital ulceration, uveitis, and erythema nodosum. Panuveitis was the most common type of uveitis in BD patients in China, although solo anterior uveitis is observed in certain patients [1]. BD exists worldwide and has significant regional differences. It is quite common along the ancient 'Silk Road' countries extending from China to the Mediterranean area [2]. Although the precise etiology of BD remains unknown, extensive studies suggest that autoimmunity and genetic factors are involved in its pathogenesis. It has been shown that polymorphisms of several genes such as human leukocyte antigens-B51 (HLA-B51), intercellular adhesion molecule-1 (ICAM-1) [3], and tumor necrosis factor-alpha (TNF-alpha) [4] are associated with susceptibility to BD. Among these genes, HLA-B51 is the most strongly associated gene with BD in different ethnic populations [5-8], particularly those from the Middle East to the Far East [9], coinciding with the distribution of BD.
###end p 12
###begin p 13
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRLs</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRHs</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRTAs</italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPAPs</italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRLs</italic>
###xml 378 386 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fc&#947;R</italic>
###xml 445 456 437 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL1&#8211;FCRL6</italic>
###xml 495 497 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 545 547 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 616 621 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1054 1059 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1208 1213 1200 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 232 237 <span type="species:ncbi:9606">human</span>
Fc receptor-like genes (FCRLs), also known as FCRHs (Fc receptor homology) or IRTAs (immunoglobulin superfamily receptor translocation associated genes) [10], and SPAPs (SH2 domain containing phosphatase anchor proteins) cluster on human chromosome 1q21-23 adjacent to the Fc receptor genes [11]. FCRLs have a high structural homology with the classical Fcgamma receptor genes (FcgammaR) and contain six Ig superfamily members that are known as FCRL1-FCRL6 according to their chromosomal order [12]. Recently, a classical study by Kochi et al. [13] in Japan found that four single nucleotide polymorphisms (SNPs) of FCRL3 (-169C/T, -110A/G, +358C/G, and +1381A/G) were associated with rheumatoid arthritis (RA) and that SNP C/T was associated with autoimmune thyroid disease (AITD) and systemic lupus erythematosus (SLE). As various autoimmune disorders may share common pathogenic pathways, genes that have been found to be involved in one autoimmune disease may also be considered as a candidate associated with other autoimmune diseases. Until now, a FCRL3 polymorphism has yet to be investigated in BD. Therefore, this study was designed to investigate the association of the aforementioned four SNPs of FCRL3 (-169C/T, -110A/G, +358C/G, and +1381A/G) with susceptibility to BD in a Chinese population, mainly with ocular involvement. The result showed a positive association of the -110G allele and the haplotype CGCG and a negative association of the haplotype TACG with BD.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 15
###begin p 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
Patients and controls were recruited from the Zhongshan Ophthalmic Center of Sun Yat-sen University (Guangzhou, P.R. China) and the First Affiliated Hospital of Chongqing Medical University (Chongqing, P.R. China). The test subjects consisted of 245 Chinese BD patients (aged 28.6+/-6.0 years) and 289 healthy controls (aged 34.2+/-10.0 years). All control subjects were matched ethnically and geographically with the patients.
###end p 16
###begin p 17
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
The diagnosis of Behcet's disease followed the criteria of the International Study Group for Behcet's disease [14]. The clinical characteristics of the patients are presented in Table 1. All subjects gave their written informed consent for this study, and the study protocol was approved by the local institutional ethics committee.
###end p 17
###begin title 18
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of patients with BD.
###end title 18
###begin p 19
###xml 12 20 <span type="species:ncbi:9606">patients</span>
N=number of patients.
###end p 19
###begin title 20
Single nucleotide polymorphisms and genotyping
###end title 20
###begin p 21
###xml 165 170 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
DNA was prepared by proteinase K digestion and salt extraction from peripheral blood of patients and controls and stored at -70 degreesC until use. The four SNPs in FCRL3, namely -169C/T ( or fcrl3_3), -110G/A ( or fcrl3_4), +358 C/G ( or fcrl3_5), and +1381A/G ( or fcrl3_6), were genotyped by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) .
###end p 21
###begin p 22
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
Genotyping of the -110A/G SNP was performed according to the method as described previously [15]. The primers of the three remaining sites were designed using Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, CA). The details of the primers and enzymes used for PCR-RFLP genotyping are presented in Table 2.
###end p 22
###begin title 23
Details of the primers and enzymes used for PCR-RFLP genotyping.
###end title 23
###begin p 24
Tm=melting temperature
###end p 24
###begin p 25
###xml 415 422 401 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 527 529 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
PCR was performed in 15 mul volumes containing 7.5 mul Premix Taq (Ex Taq Version; TaKaRa Biotechnology Co. Ltd, Dalian, China), 0.5 mul primers (10 mumol/l), and 0.1 mug of genomic DNA. The PCR products were then digested by the proper restriction enzymes and separated by electrophoresis on 2~3% agarose gels and stained with GoldViewtrade mark (SBS Genetech, Beijing, China). The images were recorded digitally. HLA-B51 genotyping was performed by the PCR-sequence specific primers (PCR-SSP) method as described previously [16].
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 154 155 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 241 242 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 378 380 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Statistical analysis was performed with the SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL). Hardy-Weinberg equilibrium (HWE) was tested by the chi2 test. We evaluated the frequency of genotypes and alleles in this study using the chi2 test or Fisher's exact test. The haplotype frequency and linkage disequilibrium (LD) of the SNPs were estimated with the  3.2 program [17]. A haplotype frequency less than 0.03 was not studied further. All the data were corrected by Bonferroni correction.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCLR3</italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 440 441 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 448 455 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 771 773 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 798 799 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 807 814 803 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 991 992 985 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 999 1006 993 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
###xml 513 521 <span type="species:ncbi:9606">patients</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 896 904 <span type="species:ncbi:9606">patients</span>
###xml 1094 1102 <span type="species:ncbi:9606">patients</span>
Four SNPs in FCRL3 were determined in 245 BD patients and 289 healthy controls. The results showed that all the cases and controls were in HWE. We analyzed LD with these four SNPs and haplotype analysis with  software, and the four SNPs of FCLR3 are not in high LD (D'=46-87; r2=0.10-0.74; Figure 1). The frequency of the G allele at the -110 site was significantly higher in patients (75.3%) than in controls (67.5%; corrected p=0.044, chi2=7.72; Table 3). The -110 GG genotype was also found to be increased in patients (p=0.007), but this significance was lost after Bonferroni correction (corrected p=0.084). The frequency of the -169C:-110G:+358C:+1381G haplotype was significantly higher in patients compared with controls (13.3% versus 7.0%, respectively; p=6.0x10-4, corrected p=0.0096, chi2=11.70; Table 4). The frequency of haplotype -169T:-110A:+358C:+1381G was significantly lower in patients than that in controls (3.0% versus 7.0%, respectively; p=0.002, corrected p=0.032, chi2=9.27; Table 4). No significant difference in the remaining three SNPs tested was observed between BD patients and controls in the distribution of other alleles and genotypes.
###end p 29
###begin p 30
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
Location and pair-wise linkage disequilibrium values of four FCRL3 SNPs in a Chinese population. These four SNPs span 1 kb of the FCRL3 region. Values of the pair-wise D' (multiply by 100) are shown in one block.
###end p 30
###begin title 31
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Frequency of alleles and genotypes of four FCRL3 SNPs in BD patients and controls.
###end title 31
###begin p 32
BD= Behcet's disease; OR=odds ratio; 95% CI=95% confidence interval; NS=not significant.
###end p 32
###begin title 33
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Haplotype frequencies in BD patients and controls.
###end title 33
###begin p 34
BD=Behcet's disease; OR=odds ratio; NS=not significant.
###end p 34
###begin p 35
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 389 392 <span type="species:ncbi:9606">men</span>
###xml 413 418 <span type="species:ncbi:9606">women</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
Since the BD patients showed different clinical features, we further analyzed the relationship between the SNPs and various clinical parameters such as uveitis, hypopyon, oral or genital ulcers, multiform skin lesions, and arthritis. No significant difference was noted between any of the mentioned clinical characteristics and the investigated SNPs. Of the 245 patients, 204 (83.3%) were men and 41 (16.7%) were women. No significant difference was found in the four SNPs between male and female patients.
###end p 35
###begin p 36
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 485 492 485 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
As HLA-B51 has been shown to be strongly associated with BD, we also investigated its frequency in patients and controls. The result showed that 99 (40.4%) patients were HLA-B51 positive as compared to 28 (9.7%) of the controls, a significant difference. HLA-B51 stratification analysis showed a significant difference for the -110 A/G allele, the AA genotype, and the haplotype CGCG and TACG. The difference, however, lost its significance when the Bonferroni correction was applied (Table 5).
###end p 36
###begin title 37
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Frequency of alleles and genotypes at four FCRL3 SNPs in HLA-B51 negative BD patients and in HLA-B51 negative controls.
###end title 37
###begin p 38
BD= Behcet's disease; OR=odds ratio; 95% CI=95% confidence interval; NS= not significant.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
In this study, we analyzed the association of four FCRL3 SNPs with BD in a Chinese population. The results showed that the -110G allele was significantly increased in the BD patients. The frequency of the haplotype CGCG was also found to be significantly increased in these patients whereas a significantly decreased frequency of haplotype TACG was noted. These results suggest that polymorphisms of FCRL3 are associated with the susceptibility to BD in a Chinese population.
###end p 40
###begin p 41
###xml 56 57 56 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 366 369 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL</italic>
###xml 752 760 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fc&#947;R</italic>
###xml 890 898 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FC&#947;R</italic>
###xml 954 956 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 957 959 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 962 966 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL</italic>
###xml 1090 1092 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1095 1100 1087 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1315 1317 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1352 1357 1344 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1399 1404 1391 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1508 1510 1496 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1648 1650 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1822 1827 1810 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1587 1593 <span type="species:ncbi:10090">murine</span>
###xml 1605 1611 <span type="species:ncbi:9606">humans</span>
BD is one of the most common uveitis entities in China [1]. Its distribution along the old 'Silk Road' and the clustering of the disease in families suggest that genetic factors may play a role in the pathogenesis of this disease. HLA-B51 has been shown to be strongly associated with BD in different ethnic populations. Little is known about the association of non-HLA genes with BD, although polymorphisms of several genes have been investigated in this disease [3,4]. In this study, we focused on the association of four FCRL3 SNPs with BD mainly because of the role this gene may play in the pathogenesis of autoimmunity and its association with other autoimmune diseases. FCRL have been shown to have a high structural homology with the classical FcgammaR, which are expressed mainly on the surface of a variety of immune cells. Moreover, previous studies showed that polymorphisms of FCgammaR were associated with a variety of autoimmune diseases [18,19]. FCRL has been found to be expressed predominantly on B cells and has also been detected at low levels in CD4+ and CD8+ T cells [13]. FCRL3 may play a role in the differentiation of B cells into autoreactive cells and has been presumed to function through modulating signal transduction via activation/inactivation of signaling tyrosine protein kinases [20]. Furthermore, the -169C/T SNP of FCRL3 has been shown to influence the level of FCRL3 expression on B cells through altering the binding affinity of the nuclear factor-kappa-B (NF-kappaB) [13], an important immunoregulatory factor, according to recent studies in both murine models and humans with diverse forms of autoimmunity [21]. It is not clear whether the -110 SNP has any functional role. The association of this SNP with BD as disclosed in our study appears to suggest a possible involvement of FCRL3 in the development of BD.
###end p 41
###begin p 42
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Our study showed a significantly higher frequency of the G allele at the -110 site in BD patients, which is consistent with that observed in patients with autoimmune Addison's disease (AAD) in a UK population [15]. This identical polymorphism between BD and AAD seemed to show a susceptibility that both have in common. Interestingly, two studies by Japanese investigators showed a decreased frequency of the G allele in the -110 site in RA and autoimmune pancreatitis [13,22]. Furthermore, a study reported by Simmonds et al. [23] showed that three of the four SNPs studied here (the -110 SNP was the exception) were associated with Graves' disease.
###end p 42
###begin p 43
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 315 321 <span type="species:ncbi:9606">people</span>
###xml 688 696 <span type="species:ncbi:9606">patients</span>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
With regard to the haplotype analysis, we found two haplotypes, CGCG and TACG, that were associated with BD. The former was found to be significantly higher in BD patients while the latter was lower in BD patients. The findings suggest that the FCRL3 -110G allele may be linked with susceptibility to BD, and those people with the haplotype CGCG are more prone to BD than those without this haplotype. On the contrary, the haplotype ATCG might be a protective haplotype to BD. Our results were different from those found in AAD [15] and SLE [24]. In the study of AAD, seven alleles and haplotypes were investigated, the haplotype TGGGAAA was found to be significantly increased among AAD patients compared to the controls. In the study of SLE, the frequency of haplotype CGA was found to be significantly higher among SLE patients compared to the controls.
###end p 43
###begin p 44
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUMO4</italic>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1258 1263 1258 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 861 869 <span type="species:ncbi:9606">patients</span>
###xml 917 925 <span type="species:ncbi:9606">patients</span>
###xml 1013 1021 <span type="species:ncbi:9606">patients</span>
###xml 1052 1060 <span type="species:ncbi:9606">patients</span>
###xml 1197 1205 <span type="species:ncbi:9606">patients</span>
###xml 1353 1361 <span type="species:ncbi:9606">patients</span>
As BD shows a variety of manifestations clinically and the aforementioned result revealed an association of the polymorphisms of FCRL3 with this disease, it is reasonable to test whether certain clinical features are linked to this polymorphism. Unexpectedly, none of the clinical features including uveitis, hypopyon, oral ulcer or genital ulcer, multiform skin lesions, and arthritis were found to be associated with the identified susceptible allele at the -110 site. Similarly, there was no association between any of the investigated clinical features and the haplotypes. These results are generally consistent with those in a previous study performed in our laboratory recently searching for an association between SUMO4 polymorphisms and BD. This study found no association between haplotype AGAT, which was already found to be significantly lower in BD patients, and any of the clinical characteristics in BD patients [25]. However, it is worthwhile to point out that there was a bias in the recruited BD patients in our current study. All the patients enrolled in this study came from ophthalmic centers, and the results merely revealed the association of the FCRL3 polymorphisms with BD patients, mainly with ocular involvement. The association of FCRL3 polymorphisms with BD in the whole population with this disease should be studied on the patients from dermatology and rheumatology centers.
###end p 44
###begin p 45
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 312 319 312 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 550 557 550 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B51</italic>
###xml 1161 1166 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
###xml 1202 1205 1202 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 610 618 <span type="species:ncbi:9606">patients</span>
###xml 812 820 <span type="species:ncbi:9606">patients</span>
###xml 977 985 <span type="species:ncbi:9606">patients</span>
###xml 1034 1042 <span type="species:ncbi:9606">patients</span>
###xml 1102 1109 <span type="species:ncbi:9606">patient</span>
Previous studies have showed that the association of FCRL3 with diseases could be more striking after stratification with some parameters [26,27]. Genetic susceptibility to BD is well documented for HLA-B51. We therefore analyzed the association of the -110 SNP and the remaining three SNPs with BD based on the HLA-B51 antigen stratification. Unfortunately, we did not find any association of these SNPs and haplotypes with BD after stratification for HLA-B51. This could be due to the insufficient sample size. Our sample size for the -110 SNP (28 HLA-B51 positive normal controls and 99 HLA-B51 positive BD patients) can only reach a 26% power value to detect a 2.0 odds ratio (OR) value at the 5% significance level. As there is a substantial difference in clinical manifestations between male and female BD patients, a stratification analysis according to sex was also performed in our study. Similarly, there was also no association following sex stratification in these patients. The small size of the sample for the female BD patients may be insufficient for this analysis. Therefore, a larger patient population is needed to clarify the association of FCRL3 with Behcet's disease in different HLA and sex status.
###end p 45
###begin p 46
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 514 516 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 953 958 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3</italic>
In conclusion, our study revealed that the -110G allele and haplotype CGCG are positively associated and haplotype TACG is negatively associated with the susceptibility to BD. These results may provide clues for the development of an adequate and effective therapy [28]. A pharmacogenomic relationship has been studied in open-angle glaucoma between beta1-adrenergic receptor with betaxolol, between prostaglandin F2alpha receptor and the latanoprost, and between glucocorticoid receptor and intraocular pressure [29]. It is important to test whether the polymorphisms revealed by our study are associated with the sensitivity of certain medicines in the treatment of BD. As a multi-systemic autoimmune disease, BD may share mechanisms in common with other autoimmune diseases. Therefore, the predisposing gene for BD may also be involved in other autoimmune diseases in a similar way. It is necessary to clarify whether the discovered polymorphisms of FCRL3 are associated with other autoimmune diseases. Furthermore, studies are needed to investigate whether the observed associations with BD are also present in other ethnic populations.
###end p 46
###begin title 47
Acknowledgments
###end title 47
###begin p 48
This work was supported by the Key Project of Natural Science Foundation (Beijing, China; 30630064) and the National Supporting Project of China (Beijing, China; 2007BAI18B10).
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Clinical features of Chinese patients with Behcet's disease.
###end article-title 50
###begin article-title 51
Behcet's disease: global epidemiology of an Old Silk Road disease.
###end article-title 51
###begin article-title 52
Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease.
###end article-title 52
###begin article-title 53
Association of TNFA promoter region haplotype in Behcet's Disease.
###end article-title 53
###begin article-title 54
Association of HLA-B51 subtypes and Behcet's disease in Spain.
###end article-title 54
###begin article-title 55
Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece.
###end article-title 55
###begin article-title 56
Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel.
###end article-title 56
###begin article-title 57
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behcet's disease.
###end article-title 57
###begin article-title 58
Molecular genetics (HLA) of Behcet's disease.
###end article-title 58
###begin article-title 59
IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells.
###end article-title 59
###begin article-title 60
An extended family of Fc receptor relatives.
###end article-title 60
###begin article-title 61
Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.
###end article-title 61
###begin article-title 62
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
###end article-title 62
###begin article-title 63
Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease.
###end article-title 63
###begin article-title 64
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association.
###end article-title 64
###begin article-title 65
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).
###end article-title 65
###begin article-title 66
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 66
###begin article-title 67
Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes.
###end article-title 67
###begin article-title 68
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups.
###end article-title 68
###begin article-title 69
Is FCRL3 a new general autoimmunity gene?
###end article-title 69
###begin article-title 70
NF-kappaB activation and inhibition: a review.
###end article-title 70
###begin article-title 71
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients.
###end article-title 71
###begin article-title 72
Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.
###end article-title 72
###begin article-title 73
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients.
###end article-title 73
###begin article-title 74
###xml 40 48 <span type="species:ncbi:9606">patients</span>
SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease.
###end article-title 74
###begin article-title 75
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis.
###end article-title 75
###begin article-title 76
Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
###end article-title 76
###begin article-title 77
Mapping translational research in personalized therapeutics: from molecular markers to health policy.
###end article-title 77
###begin article-title 78
Pharmacogenomics of Open-Angle Glaucoma.
###end article-title 78

